about
The role of protein elongation factor eEF1A2 in ovarian cancerA multiscale mathematical model of cancer, and its use in analyzing irradiation therapiesCancer is a preventable disease that requires major lifestyle changesInduction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cellsKaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathwayRegulation of cellular response to oncogenic and oxidative stress by Seladin-1Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisMAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activityp600, a unique protein required for membrane morphogenesis and cell survival.Comparative analysis of cancer genes in the human and chimpanzee genomes.Shelterin complex and associated factors at human telomeresEndocrine-disrupting chemicals: an Endocrine Society scientific statementDoes breast cancer start in the womb?Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegenerationNotch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinasesInduction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposureOn evolutionary origin of cancerModels of breast cancer: is merging human and animal models the future?Models of breast cancer: quo vadis, animal modeling?Thymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice ModelsUnderstanding Genotype-Phenotype Effects in Cancer via Network ApproachesStudies of Tumor Suppressor Genes via Chromosome EngineeringEpigenetics advancing personalized nanomedicine in cancer therapyMatrix and backstage: cellular substrates for viral vaccinesMYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitorsFunctional impact of cancer-associated mutations in the tumor suppressor protein ING4Gli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitorsApigenin: a promising molecule for cancer preventionPulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanismsSystems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"Evolutionary constraint and disease associations of post-translational modification sites in human genomesEndo180 binds to the C-terminal region of type I collagenMouse models of human disease: An evolutionary perspectiveIdentifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive SetsEvolved tumor suppression: why are we so good at not getting cancer?Cancer: evolutionary, genetic and epigenetic aspectsReduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidaseThe biological sense of cancer: a hypothesisPrinciples of cancer therapy: oncogene and non-oncogene addictionAre animal models predictive for humans?
P2860
Q21093260-55F46E04-38FC-4EC5-9EEF-FEEE575DE579Q21245224-27C95D85-3660-4EF5-A5A2-37A294A385F8Q22252614-C19183B6-2B4A-4020-A84A-607FC5B08D6DQ24297524-5A0384FE-0052-4D6F-B562-C8C98A6924A2Q24316207-9B025CE6-6B25-46B5-ACD0-D22CA6444F25Q24319120-2BCAA7D4-EAF8-4D6F-AEA7-4B3D7BA6B91EQ24321673-384F9DE0-7C97-403A-BB35-550C3E5C12EDQ24338637-AF0551C5-290F-4E33-B151-95F4103B9E87Q24533398-421312C5-CDBB-444B-9C0E-56A51ED039B9Q24541311-F7D96858-0846-402D-B76F-BBA13BA9356EQ24601577-2994ABB9-8CC5-4006-A04F-13D65C750A50Q24651457-2E631517-D141-496E-B4FA-637B1B834F38Q24652548-8A9A1591-D17D-4C0D-9A80-690CC2B443F5Q24676501-69AB1061-06A2-47B0-9059-9DA6079DFB2FQ24680631-C45F9753-4FDC-40B0-A7F4-EC46E34B5B19Q24682426-C5F2C4E1-5C20-49E8-A71D-309A46DC355DQ24803579-C6FAAEAE-2B78-419F-A131-A0306855CC8AQ24803657-E3523C74-5FBC-4AFE-A1C3-D416CD77DCAEQ24803741-E776FDC7-05D9-46E9-A5DF-B8A226C746F7Q26745612-03CCCC02-AD51-46E4-A918-CEC287090B4CQ26766543-EFABBE80-B65A-4F71-96C8-DDA306EEC5EEQ26771240-205EB46A-424E-49A9-AA5A-0EFB2CFDA638Q27010637-B11274AD-1F6A-4BA5-BB7D-E7CBF4B5C03FQ27025941-6D6B4719-052B-46A5-9CD4-05B0EF68949EQ27350187-18BCC1B1-D6B2-4C1F-861A-79BA1C0D21ABQ27664047-D75FE189-C848-4CA4-A2C3-8E6E4DA8069BQ28248615-4D581987-2E55-4C89-9A24-8ABECC94D65EQ28277257-028D44DD-1273-4144-8693-1CAC29669A8CQ28297490-4209B8F8-6B69-4BB6-AA4D-5F0EBD3DDC36Q28391909-5D1A6D7A-16D1-41BE-8F6E-D7CA8DFE84F1Q28543059-D0DDE3E7-F03F-409F-8787-01162A699818Q28573926-F8B662D1-A727-4D6A-8B2A-FD26564197FCQ28602393-7AFE5A0D-E3CB-479D-AAE9-B7C449BBE30FQ28608346-BE4FA997-28BA-4A5D-9164-DE3D4140FDEBQ28681637-C6CA5F59-D036-4BCE-8FA1-CFD9CB4C9462Q28728960-5876B3E5-E712-4AC6-B90C-24732E7C0A3FQ28729113-B269F40A-0933-4C8D-805A-CF974419F8DDQ28763945-D6E5D0A9-E51D-4917-A38C-FCDCB269F27FQ29616779-B4C7595C-BEA8-4C0F-B6F5-79261D28D1EFQ30374372-BF8D6612-0BCE-41E2-A7F8-B6796C177889
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Modelling the molecular circuitry of cancer.
@ast
Modelling the molecular circuitry of cancer.
@en
Modelling the molecular circuitry of cancer.
@nl
type
label
Modelling the molecular circuitry of cancer.
@ast
Modelling the molecular circuitry of cancer.
@en
Modelling the molecular circuitry of cancer.
@nl
prefLabel
Modelling the molecular circuitry of cancer.
@ast
Modelling the molecular circuitry of cancer.
@en
Modelling the molecular circuitry of cancer.
@nl
P356
P1476
Modelling the molecular circuitry of cancer.
@en
P2093
William C Hahn
P2888
P304
P356
10.1038/NRC795
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1045099768